Key facts
- Notable investors include Unity Ventures (China), Chengshu Capital, Dowell Service Group, Hangzhou Haibang Fenghua Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Lynmou
- ·The full record, as it builds
Funding rounds
No funding rounds for Lynmou are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lynmou
Developer and manufacturer of endoscope system designed for upper gastrointestinal series (UGI). The company focuses on developing a whole solution for gastrointestinal system test and examination, providing advanced equipment solution for UGI testing.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- lynmou.com/
- Ownership
- Privately Held (backing)
Lynmou doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lynmou shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lynmou in its N-PORT filings yet. We sweep new filings monthly.